OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ATG-101 Is a Tetravalent PD-L1×4-1BB Bispecific Antibody That Stimulates Antitumor Immunity through PD-L1 Blockade and PD-L1–Directed 4-1BB Activation
Hui Yuwen, Huajing Wang, Tengteng Li, et al.
Cancer Research (2024) Vol. 84, Iss. 10, pp. 1680-1698
Open Access | Times Cited: 6
Hui Yuwen, Huajing Wang, Tengteng Li, et al.
Cancer Research (2024) Vol. 84, Iss. 10, pp. 1680-1698
Open Access | Times Cited: 6
Showing 6 citing articles:
Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance
Manshi Yang, Mengying Cui, Yang Sun, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Manshi Yang, Mengying Cui, Yang Sun, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 17
Orchestrating NK and T cells via tri-specific nano-antibodies for synergistic antitumor immunity
Qian‐Ni Ye, Long Zhu, Jie Liang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Qian‐Ni Ye, Long Zhu, Jie Liang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Dual targeting PD-L1 and 4-1BB to overcome dendritic cell-mediated lenalidomide resistance in follicular lymphoma
Zhong Zheng, Jian-Biao Wang, Rui Sun, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Zhong Zheng, Jian-Biao Wang, Rui Sun, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
New insights into cancer immune checkpoints landscape from single-cell RNA sequencing
Qian Wang, Jiahui He, Tianyu Lei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 3, pp. 189298-189298
Closed Access
Qian Wang, Jiahui He, Tianyu Lei, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 3, pp. 189298-189298
Closed Access
Striking the Balance with a PD-L1×4–1BB Bispecific Antibody
JongHoon Ha, Adam Grippin, Betty Y.S. Kim, et al.
Cancer Research (2024) Vol. 84, Iss. 10, pp. 1546-1547
Closed Access | Times Cited: 2
JongHoon Ha, Adam Grippin, Betty Y.S. Kim, et al.
Cancer Research (2024) Vol. 84, Iss. 10, pp. 1546-1547
Closed Access | Times Cited: 2
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
Prathap Nagaraja Shastri, Nirav N. Shah, Martin Lechmann, et al.
Clinical Pharmacology & Therapeutics (2024)
Closed Access | Times Cited: 1
Prathap Nagaraja Shastri, Nirav N. Shah, Martin Lechmann, et al.
Clinical Pharmacology & Therapeutics (2024)
Closed Access | Times Cited: 1
